STAAR Surgical Company (STAA) compared with its closest peers (RXST, KIDS, CERS, LMAT, AXGN): P/E 298.3 vs industry 29.8. Peer set by Medical Equipment; 10 comparable device makers. First-party data.
RxSight and National Vision share STAAR Surgical's sub-industry, ophthalmic goods makers.
| Company | Market Cap | P/E |
|---|---|---|
| RxSight, Inc. (RXST) | $291.43M | -11.0 |
| OrthoPediatrics Corp. (KIDS) | $595.30M | -10.5 |
| Cerus Corporation (CERS) | $525.98M | -25.6 |
| LeMaitre Vascular, Inc. (LMAT) | $1.87B | 28.5 |
| AxoGen, Inc. (AXGN) | $2.60B | -96.3 |
| National Vision Holdings, Inc. (EYE) | $1.35B | 28.9 |
| Treace Medical Concepts, Inc. (TMCI) | $304.90M | -2.6 |
| Cytek Biosciences, Inc. (CTKB) | $609.62M | -9.7 |
| SI-BONE, Inc. (SIBN) | $858.95M | -44.8 |
| Lakeland Industries, Inc. (LAKE) | $116.31M | -3.6 |
| Stock P/E | 298.3 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 29.8 |
| vs Sector | 1281.3% |
| vs Industry | 902.6% |
STAA overview · STAA earnings · STAA financials · STAA KPIs · STAA documents · STAA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.